(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity
Open Access
Abstract
Topoisomerase (TOP) I plays a major role in the process of supercoiled DNA relaxation, thereby facilitating DNA replication and cell cycle progression. The expression and enzymatic activity of TOP I is positively correlated with tumor progression. Although the anticancer activity of (S)-10-Hydroxycamptothecin (HCPT), a TOP I specific inhibitor, has been reported in various cancers, the effect of HCPT on esophageal cancer is yet to be examined. In this study, we investigate the potential of HCPT to inhibit the growth of ESCC cells in vitro and verify its anti-tumor activity in vivo by using a patient-derived xenograft (PDX) tumor model in mice. Our study revealed the overexpression of TOP I in ESCC cells and treatment with HCPT inhibited TOP I enzymatic activity at 24 h and decreased expression at 48 h and 72 h. HCPT also induced DNA damage by increasing the expression of H2A.XS139. HCPT significantly decreased the proliferation and anchorage-independent growth of ESCC cells (KYSE410, KYSE510, KYSE30, and KYSE450). Mechanistically, HCPT inhibited the G2/M phase cell cycle transition, decreased the expression of cyclin B1, and elevated p21 expression. In addition, HCPT stimulated ESCC cells apoptosis, which was associated with elevated expression of cleaved PARP, cleaved caspase-3, cleaved caspase-7, Bax, Bim, and inhibition of Bcl-2 expression. HCPT dramatically suppressed PDX tumor growth and decreased the expression of Ki-67 and TOP I and increased the level of cleaved caspase-3 and H2A.XS139 expression. Taken together, our data suggested that HCPT inhibited ESCC growth, arrested cell cycle progression, and induced apoptosis both in vitro and in vivo via decreasing the expression and activity of TOP I enzyme.Keywords
Funding Information
- National Natural Science Foundation of China (NSFC81672767, NSFC81972839)
This publication has 38 references indexed in Scilit:
- Topoisomerase I as a Biomarker: Detection of Activity at the Single Molecule LevelSensors, 2014
- Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expressionWorld Journal of Surgical Oncology, 2013
- R Loops: From Transcription Byproducts to Threats to Genome StabilityMolecular Cell, 2012
- Topoisomerase I expression in tumors as a biological marker for CPT-11 chemosensitivity in patients with colorectal cancerSurgery Today, 2011
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- CPT‐11 May Provide Therapeutic Efficacy for Esophageal Squamous Cell Cancer and the Effects Correlate with the Level of DNA Topoisomerase I ProteinJapanese Journal of Cancer Research, 2001
- Apoptosis induction and cell cycle perturbation in human hepatoma Hep G2 cells by 10-hydroxycamptothecinAnti-Cancer Drugs, 1999
- Immunohistochemical detection of DNA topoisomerase I in formalin fixed, paraffin wax embedded normal tissues and in ovarian carcinomas.Molecular Pathology, 1997
- Differentiation induction of human promyelocytic leukemia cells by 10-hydioxycamptothecin, a DNA topoisomerase I inhibitorDifferentiation, 1991
- Topoisomerase I interacts with transcribed regions in Drosophila cellsCell, 1986